PS
Parambath Sreenivasan Padmanabhan Nair
About Parambath Sreenivasan Padmanabhan Nair
Data last updated:
Parambath Sreenivasan Padmanabhan Nair was a Nominee Director at Senses Pharmaceuticals Private Limited (2020–2022), Director at Til Healthcare Private Limited (2016–2022) and Director at Crecer Realty Private Limited (2018–2022), and held 4 more directorships. The companies operate in Pharma, Financial Services and Healthcare.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Nominee Director | 09 Jun 2020 | 2008 | ₹26.08 Cr (FY 2025) | Active | |
| Director | 14 Sep 2016 | 1991 | ₹267 Cr (FY 2025) | Active | |
| Director | 27 Jul 2018 | 2018 | Strike Off | ||
| Director | 15 Jul 2004 | 1990 | ₹29.20 Cr (FY 2025) | Active | |
| Additional Director | 25 Dec 2019 | 2012 | ₹26.21 Cr (FY 2025) | Active | |
| Designated Partner | 26 Dec 2018 | 2018 | Active | ||
| Director | 31 Dec 2009 | 2009 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Parambath Sreenivasan Padmanabhan Nair
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Parambath Sreenivasan Padmanabhan Nair
Parambath Sreenivasan Padmanabhan Nair was first appointed on 15 Jul 2004 as Director at Universal Pharmaceuticals Private Limited. The most recent appointment on record is 09 Jun 2020 at Senses Pharmaceuticals Private Limited.
Parambath Sreenivasan Padmanabhan Nair held 7 earlier board appointments: Senses Pharmaceuticals Private Limited (Nominee Director, 09 Jun 2020 to 28 Apr 2022); Til Healthcare Private Limited (Director, 14 Sep 2016 to 25 Apr 2022); Crecer Realty Private Limited (Director, 27 Jul 2018 to 28 Apr 2022); Universal Pharmaceuticals Private Limited (Director, 15 Jul 2004 to 25 Apr 2022); Transe Vision Care Private Limited (Additional Director, 25 Dec 2019 to 28 Apr 2022); and 2 more.